• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

注意力缺陷多动障碍:研究与实践中的见解、进展与挑战

Attention-deficit/hyperactivity disorder: insights, advances and challenges in research and practice.

作者信息

Prasad Siva, Kumminimana Rahul

机构信息

Institute for Communicative and Cognitive Neurosciences (ICCONS), Shoranur, Kerala, India.

出版信息

Postep Psychiatr Neurol. 2025 Sep;34(3):196-206. doi: 10.5114/ppn.2025.153717. Epub 2025 Aug 25.

DOI:10.5114/ppn.2025.153717
PMID:40959688
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12435561/
Abstract

PURPOSE

This review mainly focuses on the aetiology of attention-deficit/hyperactivity disorder (ADHD) including genetic, neuro-biological, biochemical and environmental factors. It also emphasizes the possible management of the disorder. This knowledge will be essential for developing therapeutic interventions and prevention measures.

VIEWS

ADHD is a neurodevelopmental psychiatric disorder, characterized by pervasive patterns of inattention, hyperactivity, or impulsivity. Globally, it affects up to 7-10% of elementary school children, and symptoms frequently persist into adulthood. Among adults, 2-5% experience ADHD symptoms worldwide. The aetiology and developmental trajectory of the disorder remain unknown. ADHD is caused by a combination of genetic, psychological, physiological, biochemical, and environmental factors. All of these factors are thought to permanently change the development of the dopaminergic and noradrenergic system, which is a fundamental neurobiological mechanism behind the disorder.

CONCLUSIONS

Untreated ADHD can have long-term effects on individuals throughout their lifetime and cause adverse life trajectories such as poor educational and occupational outcomes, substance addiction, accidents, suicide, criminal activity, and co-occurring mental and physical health disorders. Principal management options include psychopharmacological treatments such as group cognitive behavioural therapy and social skills training, parent education programmes, and school-based initiatives, as well as medication employing stimulants and non-stimulants.

摘要

目的

本综述主要关注注意力缺陷多动障碍(ADHD)的病因,包括遗传、神经生物学、生物化学和环境因素。它还强调了该疾病可能的管理方法。这些知识对于开发治疗干预措施和预防措施至关重要。

观点

ADHD是一种神经发育性精神障碍,其特征是普遍存在注意力不集中、多动或冲动行为模式。在全球范围内,它影响着高达7%至10%的小学生,症状常常持续到成年期。在成年人中,全球有2%至5%的人存在ADHD症状。该疾病的病因和发展轨迹仍然不明。ADHD是由遗传、心理、生理、生物化学和环境因素共同作用引起的。所有这些因素被认为会永久性地改变多巴胺能和去甲肾上腺素能系统的发育,这是该疾病背后的一种基本神经生物学机制。

结论

未经治疗的ADHD会对个体一生产生长期影响,并导致不良的生活轨迹,如教育和职业成就不佳、药物成瘾、事故、自杀、犯罪活动以及并发的身心健康障碍。主要的管理选择包括心理药物治疗,如团体认知行为疗法和社交技能训练、家长教育项目、学校倡议,以及使用兴奋剂和非兴奋剂的药物治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be4/12435561/74a9a823703b/PPN-34-56582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be4/12435561/a7daead5c267/PPN-34-56582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be4/12435561/74a9a823703b/PPN-34-56582-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be4/12435561/a7daead5c267/PPN-34-56582-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3be4/12435561/74a9a823703b/PPN-34-56582-g002.jpg

相似文献

1
Attention-deficit/hyperactivity disorder: insights, advances and challenges in research and practice.注意力缺陷多动障碍:研究与实践中的见解、进展与挑战
Postep Psychiatr Neurol. 2025 Sep;34(3):196-206. doi: 10.5114/ppn.2025.153717. Epub 2025 Aug 25.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years.针对5至18岁儿童注意力缺陷多动障碍(ADHD)的家长培训干预措施。
Cochrane Database Syst Rev. 2011 Dec 7;2011(12):CD003018. doi: 10.1002/14651858.CD003018.pub3.
4
Bupropion for attention deficit hyperactivity disorder (ADHD) in adults.安非他酮用于治疗成人注意力缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2017 Oct 2;10(10):CD009504. doi: 10.1002/14651858.CD009504.pub2.
5
Methylphenidate for children and adolescents with autism spectrum disorder.用于治疗自闭症谱系障碍儿童和青少年的哌醋甲酯
Cochrane Database Syst Rev. 2017 Nov 21;11(11):CD011144. doi: 10.1002/14651858.CD011144.pub2.
6
Short-Term Memory Impairment短期记忆障碍
7
Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.速释型哌甲酯用于治疗成人注意力缺陷多动障碍(ADHD)
Cochrane Database Syst Rev. 2014 Sep 18(9):CD005041. doi: 10.1002/14651858.CD005041.pub2.
8
Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents.多不饱和脂肪酸(PUFA)治疗儿童和青少年注意缺陷多动障碍(ADHD)。
Cochrane Database Syst Rev. 2023 Apr 14;4(4):CD007986. doi: 10.1002/14651858.CD007986.pub3.
9
Sexual Harassment and Prevention Training性骚扰与预防培训
10
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).用于治疗儿童和青少年注意力缺陷多动障碍(ADHD)的哌甲酯。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD009885. doi: 10.1002/14651858.CD009885.pub2.

本文引用的文献

1
Epigenetic age across development in children and adolescents with ADHD.患有注意力缺陷多动障碍的儿童和青少年在发育过程中的表观遗传年龄。
Psychiatry Res. 2025 Mar;345:116373. doi: 10.1016/j.psychres.2025.116373. Epub 2025 Jan 20.
2
Parenting Styles and Attention Deficit Hyperactivity Disorder in the South Asian Population: A Narrative Review.南亚人群中的养育方式与注意力缺陷多动障碍:一项叙述性综述
Cureus. 2024 Dec 2;16(12):e74967. doi: 10.7759/cureus.74967. eCollection 2024 Dec.
3
Attention-Deficit/Hyperactivity Disorder Diagnosis, Treatment, and Telehealth Use in Adults - National Center for Health Statistics Rapid Surveys System, United States, October-November 2023.
注意缺陷多动障碍(ADHD)的成人诊断、治疗和远程医疗使用情况 - 美国国家卫生统计中心快速调查系统,2023 年 10 月至 11 月。
MMWR Morb Mortal Wkly Rep. 2024 Oct 10;73(40):890-895. doi: 10.15585/mmwr.mm7340a1.
4
Attention-Deficit/Hyperactivity Disorder in Children Ages 5-17 Years: United States, 2020-2022.儿童注意缺陷多动障碍:2020-2022 年美国 5-17 岁儿童患病情况。
NCHS Data Brief. 2024 Mar(499):1-9.
5
Early childhood exposure to environmental phenols and parabens, phthalates, organophosphate pesticides, and trace elements in association with attention deficit hyperactivity disorder (ADHD) symptoms in the CHARGE study.在 CHARGE 研究中,儿童早期接触环境酚类、对羟基苯甲酸酯、邻苯二甲酸酯、有机磷农药和微量元素与注意力缺陷多动障碍(ADHD)症状有关。
Environ Health. 2024 Mar 14;23(1):27. doi: 10.1186/s12940-024-01065-3.
6
Prevalence of attention deficit and hyperactive disorders in South Asian countries: A systematic review and meta-analysis of cross-sectional surveys from 1980 to 2023.南亚国家注意力缺陷多动障碍的患病率:对1980年至2023年横断面调查的系统评价和荟萃分析。
Asian J Psychiatr. 2024 Apr;94:103970. doi: 10.1016/j.ajp.2024.103970. Epub 2024 Feb 12.
7
Adverse Childhood Experiences and Attention Deficit-Hyperactivity Disorder Diagnosis and Severity: An Update.童年不良经历与注意力缺陷多动障碍的诊断及严重程度:最新进展
Acad Pediatr. 2024 Apr;24(3):389-390. doi: 10.1016/j.acap.2024.01.014. Epub 2024 Jan 24.
8
Prevalence of attention-deficit hyperactivity disorder in children, adolescents and adults in the Middle East and North Africa region: a systematic review and meta-analysis.中东和北非地区儿童、青少年和成年人注意缺陷多动障碍的患病率:系统评价和荟萃分析。
BMJ Open. 2024 Jan 18;14(1):e078849. doi: 10.1136/bmjopen-2023-078849.
9
Prevalence of attention deficit hyperactivity disorder in adults: Umbrella review of evidence generated across the globe.成人注意力缺陷多动障碍的患病率:全球证据的综合评价
Psychiatry Res. 2023 Oct;328:115449. doi: 10.1016/j.psychres.2023.115449. Epub 2023 Sep 9.
10
Incidence, prevalence, and global burden of ADHD from 1990 to 2019 across 204 countries: data, with critical re-analysis, from the Global Burden of Disease study.1990 年至 2019 年期间,全球 204 个国家的 ADHD 发病率、患病率和疾病负担:来自全球疾病负担研究的具有关键重新分析的数据。
Mol Psychiatry. 2023 Nov;28(11):4823-4830. doi: 10.1038/s41380-023-02228-3. Epub 2023 Sep 8.